The congress opened with a plenary session that discussed and debated how to decode current disruptions seen in pharmaceutical markets globally.

Intelligent Legal Solutions (ILS) develops software that helps investment fund lawyers automate side letter and MFN workflows ...

Although major pharmaceutical companies have fallen in line with President Donald Trump’s “most favored nation” (MFN) drug pricing agenda, the specifics of their negotiated concessions and the actu | ...

Intelligent Legal Solutions (ILS), a global legal technology company developing software to allow investment funds lawyers to automate key processes like side letter management, comment memo ...

OnTrac today announced a Q2 expansion of its marketplace seller and small-quantity pickup program into additional high-volume ...

Experts unpacked MFN drug pricing, expired ACA subsidies, and IRA fallout for community oncology in a recent webinar. The panelists were Lindsay Bealor Greenleaf, JD, MBA, head of market access policy ...

Alice Valdur Curran joined the Pharmaceutical Executive Podcast to discuss the ongoing strategizing for MFN pricing in the pharma industry. With the launch of TrumpRx, the industry has a better idea ...

Danish experts now fear that more pharma companies will withdraw medicines from Denmark to avoid being penalised in the US market ...

The Centers for Medicare & Medicaid Services (CMS) in the US has extended the deadline for companies to take part in its ...

Denmark and Sweden are assessing how Trump’s 'Most Favoured Nation' push is affecting medicine access, now and long-term, despite safeguards in their value-based models ...

On the digital front, India and the EU have pledged to remove unwarranted obstacles to online trade and to foster an open and ...

It deprives congressional Democrats of the ability to take credit for Trump’s result or to look like reasonable, bipartisan people interested in collaborating with the president. And as Democratic ...